{"id":"W4410804811","doi":"10.1200/jco.2025.43.16_suppl.tps8667","title":"A phase 2 safety and efficacy study of PRT3789 in combination with pembrolizumab in patients with advanced or metastatic solid tumors and a <i>SMARCA4</i> mutation.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Internal medicine; Solid tumor; Cancer research; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009559346,0.001587151,0.00218083,0.0004791234,0.000360957,0.001078963,0.0007320906,0.00125334,0.003567001],"category_scores_gemma":[0.0006652463,0.0007014521,0.001353316,0.0003977525,0.0009079527,0.001153863,0.0003089987,0.003104467,0.001138026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001089318,"about_ca_system_score_gemma":0.001324915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001243727,"about_ca_topic_score_gemma":0.002260842,"domain_scores_codex":[0.9996698,0.0001152592,0.00001164548,0.00006983066,0.0000410981,0.00009238998],"domain_scores_gemma":[0.9995614,0.00004400437,0.00007230987,0.00004188968,0.00003739928,0.0002429426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7052025,0.09637368,0.004966469,0.001033793,0.002143859,0.0004660067,0.0003961363,0.003378297,0.07418365,0.0005684954,0.005418465,0.1058686],"study_design_scores_gemma":[0.4435963,0.5296249,0.0110902,0.00004608971,0.0006963517,0.0005113246,0.00009067395,0.001925017,0.005561919,0.000369751,0.006438168,0.00004936109],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868051,0.00419049,0.001127841,0.0005719743,0.0002816297,0.003232717,0.001409245,0.0001455052,0.002235558],"genre_scores_gemma":[0.9858512,0.002815018,0.001578282,0.0009387193,0.0002299742,0.002775687,0.002391022,0.000051813,0.003368212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003567001,"threshold_uncertainty_score":0.01193285,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02425902067346029,"score_gpt":0.4131760571855009,"score_spread":0.3889170365120406,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}